Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 51 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL01 NCT00198991


2.		Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL03 NCT00199004


3.		AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				16 and over				Other				MK1-192 NCT00180128


4.		Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				60 and over				Other				AML_GT60_DD NCT00180167


5.		Study Treatment to Low Risk ALL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 and under				Other				LAL-BR/2001 NCT00526175


6.		LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				65 and under				Other				LAL-Ph-2000 NCT00526305


7.		Study Treatment for Children High Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				16 and under				Other				LAL-AR-N-2005 NCT00526409


8.		German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				15 to 65				Other				GMALL04 NCT00199017

Last Modified: 10/31/2008 First Published: 3/22/2007


9.		Phase II/III Randomized Study of Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Biomarker/Laboratory analysis, Treatment				Active				Any age				Other				UHW-AML16 EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

Last Modified: 12/28/2008 First Published: 4/1/1999


10.		Phase III Randomized Study of Dexamethasone Versus Prednisolone During Induction Therapy and Prolonged Versus Conventional Duration Asparaginase During Consolidation and Late Intensification Therapy in Children With Acute Lymphoblastic Leukemia or Lymphoblastic Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 18				Other				EORTC-58951 NCT00003728

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute